SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0000950123-10-010610
Filing Date
2010-02-10
Accepted
2010-02-09 20:36:29
Documents
9

Document Format Files

Seq Description Document Type Size
1 424B3 a54656b3e424b3.htm 424B3 3063300
2 GRAPHIC a54656b3a5465601.gif GRAPHIC 5065
3 GRAPHIC a54656b3a5465602.gif GRAPHIC 4973
4 GRAPHIC a54656b3a5465603.gif GRAPHIC 5211
5 GRAPHIC a54656b3a5465608.gif GRAPHIC 3485
6 GRAPHIC a54656b3a5465604.gif GRAPHIC 54046
7 GRAPHIC a54656b3a5465605.gif GRAPHIC 6352
8 GRAPHIC a54656b3a5465606.gif GRAPHIC 14528
9 GRAPHIC a54656b3a5465607.gif GRAPHIC 10290
  Complete submission text file 0000950123-10-010610.txt   3209160
Mailing Address 4365 EXECUTIVE DRIVE, SUITE 300 SAN DIEGO CA 92121
Business Address 4365 EXECUTIVE DRIVE, SUITE 300 SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-163911 | Film No.: 10586026
SIC: 2836 Biological Products, (No Diagnostic Substances)